Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals

Detalhes bibliográficos
Autor(a) principal: Brito, Margarida Dantas de
Data de Publicação: 2014
Outros Autores: Martins, Ângelo, Andrade, Joaquim, Guimarães, José, Mariz, José
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360
Resumo: Introduction: Langerhans cell histiocytosis is a heterogeneous disease, more frequently diagnosed during childhood. Between 1/2001 and 12/2013, 20 adult patients were admitted at both Hospitals. This work aimed at ccharacterizing this population.Material and Methods: Retrospective study, review of clinical records.Results: 16 patients were eligible to analysis. The median age at diagnosis was 34 years (15-48); 10 males and 6 females. The referral motive was: respiratory complaints – 37.5%; bone changes – 37.5%; dental complaints - 25%; constitutional symptoms - 19%; mucocutaneous lesions – 6% and one patient (6%) was accidentally diagnosed after a thyroidectomy. The tissue of histological diagnosis was: bone - 50%; pulmonary tissue – 37.5%; liver, genital mucosa and thyroid - 6%, respectively. Staging was: single organ involvement (uni/multifocal) - 69% and multisystem disease in 31%. Clinical re-evaluation of these cases is being done at the moment. The median follow up was 5 years (1 month – 11 years) and the overall survival was 92%. Currently 19% are alive without signs of disease; 44% are alive with disease; 25% are under treatment and 12% died.Discussion: These results agree with published literature. Considering the actual guidelines 56% patients were incompletely staged, which probably lead to suboptimal treatment. There is heterogeneity of clinical procedures aiming at staging and treatment of these patients.Conclusion: The diagnosis of adulthood Langerhans cell histiocytosis is difficult considering the diversity of clinical behavior. Frequently this also leads to diagnosis delay. Prospective international clinical trials enrolling adult patients are important.Keywords: Adult; Histiocytosis, Langerhans-Cell.
id RCAP_e39da51ab9b60d8543689ce6502ab9f9
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/5360
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese HospitalsHistiocitose de Largerhans no Adulto: Experiência de Dois Hospitais PortuguesesIntroduction: Langerhans cell histiocytosis is a heterogeneous disease, more frequently diagnosed during childhood. Between 1/2001 and 12/2013, 20 adult patients were admitted at both Hospitals. This work aimed at ccharacterizing this population.Material and Methods: Retrospective study, review of clinical records.Results: 16 patients were eligible to analysis. The median age at diagnosis was 34 years (15-48); 10 males and 6 females. The referral motive was: respiratory complaints – 37.5%; bone changes – 37.5%; dental complaints - 25%; constitutional symptoms - 19%; mucocutaneous lesions – 6% and one patient (6%) was accidentally diagnosed after a thyroidectomy. The tissue of histological diagnosis was: bone - 50%; pulmonary tissue – 37.5%; liver, genital mucosa and thyroid - 6%, respectively. Staging was: single organ involvement (uni/multifocal) - 69% and multisystem disease in 31%. Clinical re-evaluation of these cases is being done at the moment. The median follow up was 5 years (1 month – 11 years) and the overall survival was 92%. Currently 19% are alive without signs of disease; 44% are alive with disease; 25% are under treatment and 12% died.Discussion: These results agree with published literature. Considering the actual guidelines 56% patients were incompletely staged, which probably lead to suboptimal treatment. There is heterogeneity of clinical procedures aiming at staging and treatment of these patients.Conclusion: The diagnosis of adulthood Langerhans cell histiocytosis is difficult considering the diversity of clinical behavior. Frequently this also leads to diagnosis delay. Prospective international clinical trials enrolling adult patients are important.Keywords: Adult; Histiocytosis, Langerhans-Cell.Introdução: A histiocitose de células de Langerhans é uma doença heterogénea e mais frequente em crianças. Entre 1/2001 e 12/2013 admitimos 20 doentes com HCL nas duas instituições. O objectivo deste trabalho foi caracterizar esta população, avaliando as formas de apresentação, o estadiamento e tratamento.Material e Métodos: Estudo retrospectivo; consulta do processo clínico.Resultados: Dos 16 doentes analisáveis verificamos uma mediana de idade 34 anos (15-48), 10 mulheres e 6 homens. Os motivos que determinaram a referenciação dos doentes foram: queixas respiratórias em 37,5%; alterações ósseas em 37,5%; queixas dentárias em 25%; sintomas constitucionais em 19%; lesões mucocutâneas em 6% e outro foi um achado histológico inesperado após tiroidectomia. O diagnóstico histológico foi obtido em: osso em 50%; pulmão em 37,5%; fígado, mucosa vulvar e peça de tiroidectomia em 6%, respectivamente. O estadiamento assumido na prática clínica foi: envolvimento de órgão único (uni/multifocal) em 69% e doença multissistémica em 31%. A mediana de seguimento foi cinco anos (dois meses-11 anos) e a sobrevivência global 92%. Actualmente: 19% estão vivos sem doença; 44% estão vivos com doença; 25% estão em tratamento e 12% morreram.Discussão: Estes resultados estão de acordo com a literatura. No entanto, segundo as recomendações actuais consideramos que 56% doentes efectuaram estudo complementar incompleto condicionando subestadiamento e provavelmente subtratamento. Verifica-se heterogeneidade de procedimentos no estadiamento e tratamento.Conclusão: Frequentemente há dificuldades e atraso no diagnóstico desta entidade clínica. São importantes estudos prospectivos internacionais na população adulta.Palavras-chave: Adulto; Histiocitose de Células de Langerhans.Ordem dos Médicos2014-12-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfimage/jpegimage/jpegimage/jpegapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360oai:ojs.www.actamedicaportuguesa.com:article/5360Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 726-730Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 726-7301646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4149https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4248https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7167https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7168https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7169https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7451Brito, Margarida Dantas deMartins, ÂngeloAndrade, JoaquimGuimarães, JoséMariz, Joséinfo:eu-repo/semantics/openAccess2022-12-20T11:04:19Zoai:ojs.www.actamedicaportuguesa.com:article/5360Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:04.448720Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
Histiocitose de Largerhans no Adulto: Experiência de Dois Hospitais Portugueses
title Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
spellingShingle Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
Brito, Margarida Dantas de
title_short Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
title_full Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
title_fullStr Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
title_full_unstemmed Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
title_sort Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
author Brito, Margarida Dantas de
author_facet Brito, Margarida Dantas de
Martins, Ângelo
Andrade, Joaquim
Guimarães, José
Mariz, José
author_role author
author2 Martins, Ângelo
Andrade, Joaquim
Guimarães, José
Mariz, José
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Brito, Margarida Dantas de
Martins, Ângelo
Andrade, Joaquim
Guimarães, José
Mariz, José
description Introduction: Langerhans cell histiocytosis is a heterogeneous disease, more frequently diagnosed during childhood. Between 1/2001 and 12/2013, 20 adult patients were admitted at both Hospitals. This work aimed at ccharacterizing this population.Material and Methods: Retrospective study, review of clinical records.Results: 16 patients were eligible to analysis. The median age at diagnosis was 34 years (15-48); 10 males and 6 females. The referral motive was: respiratory complaints – 37.5%; bone changes – 37.5%; dental complaints - 25%; constitutional symptoms - 19%; mucocutaneous lesions – 6% and one patient (6%) was accidentally diagnosed after a thyroidectomy. The tissue of histological diagnosis was: bone - 50%; pulmonary tissue – 37.5%; liver, genital mucosa and thyroid - 6%, respectively. Staging was: single organ involvement (uni/multifocal) - 69% and multisystem disease in 31%. Clinical re-evaluation of these cases is being done at the moment. The median follow up was 5 years (1 month – 11 years) and the overall survival was 92%. Currently 19% are alive without signs of disease; 44% are alive with disease; 25% are under treatment and 12% died.Discussion: These results agree with published literature. Considering the actual guidelines 56% patients were incompletely staged, which probably lead to suboptimal treatment. There is heterogeneity of clinical procedures aiming at staging and treatment of these patients.Conclusion: The diagnosis of adulthood Langerhans cell histiocytosis is difficult considering the diversity of clinical behavior. Frequently this also leads to diagnosis delay. Prospective international clinical trials enrolling adult patients are important.Keywords: Adult; Histiocytosis, Langerhans-Cell.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360
oai:ojs.www.actamedicaportuguesa.com:article/5360
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/5360
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4149
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4248
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7167
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7168
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7169
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7451
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
image/jpeg
image/jpeg
image/jpeg
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 726-730
Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 726-730
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130642167889920